-
3 Branded Formulations, Custom Synthesis and Research-Led CDMO Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Divi’s Laboratories and Anthem Biosciences
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
No Comments
Pharma Manufacturing and Research Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Divi’s Laboratories and Anthem Biosciences. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories
- October 21, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Pharma Brand and Ingredient Stocks with a strong future roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 CDMO Stocks With a Strong Future Roadmap: Divi’s Laboratories, Laurus Labs and Neuland Laboratories
- October 6, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Divi’s Laboratories, Laurus Labs and Neuland Laboratories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
10 Stocks to Buy Today: Pharma, Energy and PSU Names on the Radar
- September 25, 2026
- Posted by: Neeraj Pandey
- Category: News
10 stocks to buy today: Cipla, Divi’s Labs, ONGC, NTPC and more, each with a technical target, stop-loss, market cap and a specific flagged risk.
-
Divi’s Laboratories results reported weak EBITDA margins in Q1FY23
- September 3, 2022
- Posted by: Sheen Hitaishi
- Category: Market
